Chemical inhibitors of VCAC3 include a variety of compounds that target different aspects of calcium signaling and voltage-gated ion channels, essential components of VCAC3's function. Tetrodotoxin is known for its ability to selectively inhibit voltage-gated sodium channels. By blocking these channels, tetrodotoxin prevents the initiation of electrical potential changes crucial for VCAC3 activity, thus directly inhibiting the protein. Similarly, ω-Conotoxin GVIA and ω-Agatoxin IVA target calcium channels specifically; ω-Conotoxin GVIA inhibits N-type calcium channels, while ω-Agatoxin IVA inhibits P/Q-type calcium channels. Both of these actions serve to reduce calcium influx, a vital trigger for VCAC3's normal function, thereby inhibiting the protein's activity. Another inhibitor, Diltiazem, alongside Verapamil and Nifedipine, blocks L-type calcium channels, which consequently decreases intracellular calcium levels and inhibits the signaling pathways that would otherwise regulate VCAC3 activity.
Further involvement in calcium regulation is seen with Ryanodine, which disrupts the function of ryanodine receptors integral to calcium release from the sarcoplasmic reticulum. This disturbance inhibits VCAC3 by altering calcium dynamics within the cell. Thapsigargin follows a similar approach by inhibiting the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to the depletion of ER calcium stores and subsequent inhibition of VCAC3. The compound 2-APB works to inhibit IP3 receptors and store-operated calcium channels, lowering intracellular calcium concentration, a necessary element for VCAC3's operation. SKF-96365 also plays a role in inhibiting receptor-mediated calcium entry and store-operated channels, thereby reducing calcium signaling and VCAC3 activity. Gadolinium(III) chloride blocks various calcium-permeable channels, including mechanosensitive ones, disrupting the calcium signaling pathways that VCAC3 relies on. Lastly, Bepridil, with its ability to inhibit multiple types of calcium channels, curtails the calcium signaling that regulates VCAC3, culminating in the functional inhibition of the protein. Each of these chemicals directly influences the ion channels and calcium-related pathways that are vital for VCAC3's activity, ensuring that its function is inhibited without affecting the protein's expression or general protein synthesis pathways.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Diltiazem | 42399-41-7 | sc-204726 sc-204726A | 1 g 5 g | $209.00 $464.00 | 4 | |
Diltiazem inhibits L-type calcium channels, which could decrease intracellular calcium levels, and since calcium signaling can regulate the activity of VCAC3, this reduction would inhibit VCAC3's function. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $374.00 | ||
Verapamil, by blocking L-type calcium channels, can inhibit the intracellular calcium signaling that VCAC3 depends on for its activity. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
Nifedipine blocks L-type calcium channels, which would lead to a decrease in calcium-dependent signaling pathways that regulate VCAC3 activity, resulting in inhibition of VCAC3. | ||||||
ω-Agatoxin IVA | 145017-83-0 | sc-302015 | 100 µg | $463.00 | ||
ω-Agatoxin IVA is an inhibitor of P/Q-type calcium channels, which are involved in the regulation of VCAC3 activity; inhibition of these channels reduces VCAC3 function. | ||||||
Ryanodine | 15662-33-6 | sc-201523 sc-201523A | 1 mg 5 mg | $223.00 $799.00 | 19 | |
Ryanodine alters the function of ryanodine receptors, which control the release of calcium from the sarcoplasmic reticulum, and dysregulation of this process can inhibit VCAC3 function. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to depletion of ER calcium stores; this disruption of calcium homeostasis can inhibit VCAC3 activity. | ||||||
2-APB | 524-95-8 | sc-201487 sc-201487A | 20 mg 100 mg | $28.00 $53.00 | 37 | |
2-APB inhibits IP3 receptors and store-operated calcium channels, which can decrease the intracellular calcium concentration that is necessary for VCAC3 function, thus inhibiting it. | ||||||
SK&F 96365 | 130495-35-1 | sc-201475 sc-201475B sc-201475A sc-201475C | 5 mg 10 mg 25 mg 50 mg | $103.00 $158.00 $397.00 $656.00 | 2 | |
SKF-96365 inhibits receptor-mediated calcium entry and store-operated channels, which would lead to reduced calcium signaling required for VCAC3 activity, effectively inhibiting VCAC3. | ||||||
Gadolinium(III) chloride | 10138-52-0 | sc-224004 sc-224004A | 5 g 25 g | $153.00 $357.00 | 4 | |
Gadolinium(III) chloride blocks mechanosensitive and other types of calcium-permeable channels, which could inhibit the calcium signaling pathways essential for VCAC3 activity. | ||||||
Bepridil | 64706-54-3 | sc-507400 | 100 mg | $1620.00 | ||
Bepridil inhibits multiple types of calcium channels, which can inhibit the calcium signaling that regulates VCAC3 activity, thereby inhibiting the function of VCAC3. | ||||||